As a clinical-stage biopharmaceutical company, Kronos Bio wanted an easy, efficient build process for its oncology studies, but struggled with the limitations of a traditional EDC system. Historically, building the study database was laborious and required extensive custom programming. Complex casebooks and forms had to be pre-built to accommodate variations, and back-and-forth UAT cycles with the EDC vendor created delays and frustration. Given the costs and constraints, Kronos Bio couldn’t build the trials it wanted. In one case, the casebook went live with a fraction of the actual study cycles because the legacy EDC system was so slow to configure.

Join for free to read